20% OFF shipping at i-pharmacy.vn on orders over $79 + up to 10% OFF products
vn
home > dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International > dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International
download picture
Dihexa MOL Changes Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link A novel agonist for the HGF receptor MET promotes differentiation of human pluripotent stem cells into hepatocytelike cells Tauran 2022 Development, Growth & Differentiation Wiley Online Library Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment Exploring the science behind Dihexa., Preclinical research examines its interaction with the HGF c Met pathway and associated neuroplasticity markers in laboratory and animal models. Human data Signaling pathway of HGF c MET in cancers. Stimulation of c MET by HGF Download Scientific Diagram
Shopping security

Shopping security

Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
Dihexa - MOL Changes
Targeting HGF/c-MET signaling to regulate the tumor microenvironment:  Implications for counteracting tumor immune evasion | Cell Communication  and Signaling | Springer Nature Link
A novel agonist for the HGF receptor MET promotes differentiation of human  pluripotent stem cells into hepatocytelike cells - Tauran - 2022 -  Development, Growth & Differentiation - Wiley Online Library
Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for  Cancer Treatment
Exploring the science behind Dihexa., Preclinical research examines its  interaction with the HGF/c-Met pathway and associated neuroplasticity  markers in laboratory and animal models. Human data ...

dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International

Item no : 56106216693
sold recently : Login >>
US$ 28.48
Pay in 4 interest-free payments of $7.12 Learn more
Min. order: 1piece

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jun 12 - Jun 17

Enjoy 20% off shipping

US$ 28.48

1-11

US$ 25.63

12-35

US$ 19.94

36-59

US$ 17.09

60+

US$40

Get now

Sign up to your membership to get coupons up to

15%

Get now

Opportunity to enjoy order discount up to 15% off

Please add the products
Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

Discover Niche Categories That Outsell dihexa hgf c-met agonist

Top-Converting Item to Boost Your Average Order

recommand products

GHK-Cu
GHK-Cu

US$ 24.31

Min. order: 1 piece

4.9 (58 reviews)

Sold : Login>>

GHK-Cu
GHK-Cu

US$ 25.39

Min. order: 1 piece

4.2 (20 reviews)

Sold : Login>>